Investment analysts at Citigroup assumed coverage on shares of Reckitt Benckiser Group (LON:RKT – Get Free Report) in a research report issued on Wednesday, Marketbeat.com reports. The firm set a “buy” rating and a GBX 7,000 price target on the stock. Citigroup’s target price would suggest a potential upside of 13.90% from the stock’s previous close.
RKT has been the subject of several other research reports. Royal Bank Of Canada cut shares of Reckitt Benckiser Group to a “sector perform” rating and reduced their price target for the company from GBX 6,400 to GBX 6,200 in a report on Wednesday. JPMorgan Chase & Co. boosted their price objective on shares of Reckitt Benckiser Group from GBX 5,500 to GBX 6,100 and gave the company a “neutral” rating in a research report on Wednesday, November 26th. Deutsche Bank Aktiengesellschaft increased their target price on Reckitt Benckiser Group from GBX 5,600 to GBX 5,700 and gave the stock a “buy” rating in a report on Friday, October 24th. Jefferies Financial Group lifted their price target on Reckitt Benckiser Group from GBX 5,500 to GBX 5,700 and gave the company a “hold” rating in a research note on Wednesday, January 7th. Finally, UBS Group restated a “buy” rating and issued a GBX 7,700 price target on shares of Reckitt Benckiser Group in a report on Friday, October 17th. Three research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, Reckitt Benckiser Group presently has a consensus rating of “Hold” and an average price target of GBX 6,279.29.
Check Out Our Latest Stock Analysis on RKT
Reckitt Benckiser Group Trading Down 0.6%
Insider Transactions at Reckitt Benckiser Group
In related news, insider Patricia Verduin bought 135 shares of the company’s stock in a transaction that occurred on Wednesday, October 29th. The shares were acquired at an average price of GBX 5,867 per share, for a total transaction of £7,920.45. Insiders own 0.42% of the company’s stock.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Recommended Stories
- Five stocks we like better than Reckitt Benckiser Group
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Look who’s buying 2 tonnes of gold… per week!
- Virtually Unknown AI Company Solving Trillion-Dollar Problem
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
